Targeting FET-Rearranged Sarcomas Through Inhibition of LSD1

Time: 3:30 pm
day: Day One

Details:

  • Understanding the scaffolding function of LSD1
  • Highlighting the seclidemstat mediated inhibition of LSD1 proteinprotein interactions
  • Evaluating the in vitro activity of seclidemstat in FET-rearranged sarcomas

Speakers: